- Mithra builds on leading position in Belgian contraceptive market
- Mithra achieves significant increase in 2016 sales
- Market trend validates Mithra’s Estetrol-based programs
Liège, Belgium January 31, 2017 – Mithra Pharmaceuticals (Euronext Brussels: MITRA), a company focused on women’s health, today announces that it increased its market share in Belgium by 0.97% to 45.84% compared to 2015, placing it ahead of Bayer and Merck. The Company also achieved an increase in sales of 4.23%.